Van Eck Associates Corp Galapagos Nv Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Galapagos Nv stock. As of the latest transaction made, Van Eck Associates Corp holds 1,153 shares of GLPG stock, worth $26,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,153
Previous 753
53.12%
Holding current value
$26,311
Previous $23,000
39.13%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GLPG
# of Institutions
84Shares Held
12.2MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$35.8 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$32.2 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$23.5 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$18.3 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$16.4 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.5B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...